If you have been diagnosed with Thyroid Eye Disease (TED), you may be looking for answers about your treatment options, and wondering what happens if your doctor recommends an infusion therapy.

Thyroid Eye Disease can affect the tissues surrounding the eyes and may cause symptoms such as eye bulging, redness, swelling, dryness, eye pain or pressure, double vision, and changes in appearance or vision.

For some patients, a specialist may recommend an FDA-approved specialty therapy such as TEPEZZA® (teprotumumab-trbw) or LUMVOA™ (veligrotug-vvze).

For patients who need specialty infusion therapy in Delaware, Infusion Solutions of Delaware provides physician-directed outpatient infusion care at three convenient locations in Dover, Milford, and Newark.

Our goal is to make specialty infusion therapy a more convenient and comfortable alternative to receiving treatment in a hospital setting.

What Is Thyroid Eye Disease?

Thyroid Eye Disease is an autoimmune condition that affects tissues around the eyes. It is commonly associated with Graves’ disease and other thyroid disorders.

When the immune system affects the tissues surrounding the eyes, inflammation and tissue changes can occur.

Symptoms may include:

• Bulging or protruding eyes
• Eye redness or swelling
• Dry, gritty, or irritated eyes
• Eye pain or pressure
• Light sensitivity
• Double vision
• Difficulty completely closing the eyes
• Changes in the appearance of the eyes
• Changes in vision

The severity and symptoms of Thyroid Eye Disease can vary from patient to patient.

If you are experiencing new, worsening, or significant eye symptoms, speak with your ophthalmologist, endocrinologist, or other healthcare provider. Sudden or severe vision changes should receive prompt medical attention.

When Is Infusion Therapy Used for Thyroid Eye Disease?

There is no single treatment plan that is right for every person with Thyroid Eye Disease.

Depending on your symptoms, disease history, severity, and overall health, your healthcare provider may recommend observation, supportive treatments, medications, surgery, or specialty therapies.

For some patients, intravenous biologic therapy may be appropriate.

Two therapies patients may hear about are TEPEZZA® and LUMVOA™.

Your prescribing healthcare provider will determine whether infusion therapy is appropriate for your individual situation.

TEPEZZA® for Thyroid Eye Disease

TEPEZZA® (teprotumumab-trbw) is an intravenous medication approved by the U.S. Food and Drug Administration for the treatment of Thyroid Eye Disease.

TEPEZZA targets the insulin-like growth factor-1 receptor (IGF-1R), a pathway involved in Thyroid Eye Disease.

The current FDA prescribing information indicates that TEPEZZA is used to treat Thyroid Eye Disease regardless of disease activity or duration. Treatment is administered intravenously according to the prescribed dosing schedule.

Whether TEPEZZA is right for you is a decision your prescribing healthcare provider will make based on your diagnosis, medical history, symptoms, and treatment goals.

LUMVOA™ for Thyroid Eye Disease

LUMVOA™ (veligrotug-vvze) is another FDA-approved treatment option for Thyroid Eye Disease.

The FDA approved LUMVOA in 2026 for the treatment of Thyroid Eye Disease regardless of disease activity or duration.

The availability of another FDA-approved therapy gives physicians an additional option when developing individualized treatment plans for patients with TED.

If your physician has recommended LUMVOA, ask Infusion Solutions of Delaware about current treatment availability, referral requirements, and insurance considerations.

TEPEZZA vs. LUMVOA: Which Treatment Is Right for Me?

If your doctor has discussed TEPEZZA or LUMVOA with you, you may wonder which medication is better.

The answer depends on your individual circumstances.

Your healthcare provider may consider:

• Your Thyroid Eye Disease history
• Whether your disease is active or chronic
• Your symptoms and severity
• Previous treatments
• Your overall health
• Potential benefits and risks
• Your insurance coverage
• Your physician’s treatment recommendation

Patients should not choose between these medications on their own.

Your ophthalmologist, endocrinologist, or other prescribing provider will determine which treatment is appropriate and provide the orders necessary for your infusion therapy.

What Happens After Your Doctor Prescribes an Infusion?

A specialty medication prescription is only one part of the process.

Patients often have questions about:

Will my insurance cover it?

Does my doctor need to send a referral?

Who handles prior authorization?

Where will I receive my infusion?

How do I schedule my treatment?

Infusion Solutions of Delaware helps coordinate many of these steps, so you don’t have to navigate the process alone.

Step 1: Your Healthcare Provider Sends the Referral

Your physician sends the appropriate referral, medication orders, and supporting medical information to Infusion Solutions of Delaware.

The practice provides physician forms for patient referrals and biologic infusion orders to help streamline communication between referring providers and the infusion center.

Step 2: Insurance Benefits Are Verified

Specialty medications can have complex insurance requirements.

Infusion Solutions of Delaware works with patients and insurance providers to help determine coverage and requirements before treatment.

Insurance participation and benefits can vary by plan, medication, and individual circumstances, so patients should confirm their specific coverage with the Infusion Solutions team and their insurance provider.

Step 3: Prior Authorization Is Coordinated

Some specialty medications require prior authorization before an insurance company approves treatment.

Infusion Solutions of Delaware has experience coordinating the administrative requirements associated with specialty infusion therapy.

The practice’s patient-access resources and referral process are designed to help coordinate information between patients, providers, and insurance companies.

That means your healthcare team can focus on your medical care while the infusion center helps work through the administrative process.

Step 4: Your Infusion Is Scheduled

Once the necessary referral, medication orders, insurance requirements, and authorizations are completed, your infusion can be scheduled.

Infusion Solutions of Delaware offers outpatient infusion therapy designed to provide patients with a convenient alternative to hospitalization and traditional home care.

Step 5: Receive Your Treatment in a Comfortable Outpatient Setting

On infusion day, your prescribed medication is administered by the clinical team according to your physician’s orders.

Your care team will monitor you during treatment and provide instructions regarding your infusion.

Infusion visits can also give you an opportunity to ask questions and learn more about your treatment plan.

Infusion Solutions of Delaware: Specialty Infusion Care Close to Home

When you need recurring infusion therapy, location matters.

Traveling to a hospital or distant treatment center for every infusion can become an unnecessary burden.

Infusion Solutions of Delaware provides specialty outpatient infusion services at three locations across Delaware:

Infusion Solutions of Delaware (Dover)

1100 Forrest Avenue
Dover, DE 19904

Phone: 302-674-4627

The Dover location is the original Infusion Solutions location and provides outpatient specialty infusion care for patients throughout central Delaware.

Infusion Solutions of Delaware (Milford)

1003 Mattlind Way
Milford, DE 19963

Phone: 302-674-4627

The Milford location provides convenient access to specialty infusion therapy for patients in southern Delaware and surrounding communities.

Infusion Solutions of Delaware (Newark)

537 Stanton Christiana Road
Newark, DE 19713

Phone: 302-683-9400

The Newark location expands access to outpatient infusion services for patients in northern Delaware and surrounding areas.

With locations in Dover, Milford, and Newark, Infusion Solutions of Delaware can help make specialty infusion treatment more accessible for patients across the state.

Why Choose Infusion Solutions of Delaware?

Receiving a specialty infusion doesn’t have to mean spending the day in a hospital.

Infusion Solutions of Delaware was established with a mission of providing high-quality outpatient infusion therapy while emphasizing quality, convenience, accessibility, and affordability.

Patients may benefit from:

• Experienced infusion professionals
• Physician-directed outpatient infusion therapy
• Convenient Delaware locations
• Insurance benefit assistance
• Prior authorization coordination
• Referral and intake support
• Coordination with prescribing physicians
• A comfortable alternative to hospital-based infusion
• Support for Medicare and many major insurance plans
• A patient-focused approach to specialty care

The practice has provided outpatient infusion services since 2006 and continues to focus on coordinated care and accessibility for Delaware patients.

Medicare and Insurance for Thyroid Eye Disease Infusions

One of the biggest questions patients have after being prescribed a specialty medication is:

“Will my insurance cover my treatment?”

Infusion Solutions of Delaware works with numerous insurance plans, including Medicare.

• Aetna
• AmeriHealth
• Blue Cross Blue Shield
• CareFirst Blue Cross Blue Shield of Maryland
• Cigna
• Cigna HealthSpring
• CoreSource
• EDS/Medicaid
• Health Options Medicaid
• Medicare
• Railroad Medicare
• TRICARE Prime and Standard
• UnitedHealthcare

Insurance plans and participation can change, and individual benefits vary. Always confirm your specific coverage and out-of-pocket responsibility with the infusion center and your insurance carrier.

You Don’t Have to Navigate Specialty Infusion Therapy Alone

Being diagnosed with Thyroid Eye Disease can be stressful enough without having to figure out the insurance and administrative process by yourself.

If your doctor recommends specialty infusion therapy, Infusion Solutions of Delaware can help coordinate the process.

From referral intake and insurance verification to prior authorization and scheduling, the team works to help move your treatment forward.

Your physician remains responsible for determining whether an infusion medication is medically appropriate for you. Infusion Solutions provides the outpatient setting and coordination needed to administer your prescribed therapy.

Looking for TEPEZZA® Infusion Therapy in Delaware?

If your ophthalmologist or other healthcare provider has prescribed TEPEZZA® for Thyroid Eye Disease, Infusion Solutions of Delaware offers Tepezza among its listed biologic infusion therapies.

With locations in Dover, Milford, and Newark, patients have access to outpatient infusion care in multiple communities across Delaware.

If you have been prescribed TEPEZZA or another specialty infusion medication, contact Infusion Solutions of Delaware to discuss the referral process, insurance requirements, prior authorization, and scheduling.

Looking for LUMVOA™ Infusion Therapy in Delaware?

LUMVOA is a newer FDA-approved treatment option for Thyroid Eye Disease.

If your healthcare provider believes LUMVOA may be appropriate for you, contact Infusion Solutions of Delaware to ask about current availability and referral requirements.

The team can help determine what documentation and insurance authorization may be required for your prescribed treatment.

Frequently Asked Questions About Thyroid Eye Disease Infusions in Delaware

Is TEPEZZA an infusion?

Yes. TEPEZZA is administered intravenously according to its FDA-approved prescribing information.

Is LUMVOA an infusion?

Yes. LUMVOA is an intravenous therapy approved by the FDA for the treatment of Thyroid Eye Disease.

Does Infusion Solutions of Delaware accept Medicare?

Yes. Medicare and Railroad Medicare are among the insurance plans accepted by Infusion Solutions of Delaware.

Does Infusion Solutions of Delaware work with other insurance companies?

Yes. The practice lists numerous participating insurance plans, including Aetna, AmeriHealth, Blue Cross Blue Shield, Cigna, TRICARE, UnitedHealthcare, Medicaid plans, and others.

Does Infusion Solutions of Delaware help with prior authorization?

The practice provides insurance and patient-support resources and coordinates the administrative requirements associated with specialty infusion therapy. Patients should contact the office regarding the specific prior authorization requirements for their medication and insurance plan.

Does my doctor have to refer me?

Your prescribing healthcare provider must determine that infusion therapy is appropriate and provide the necessary orders. Infusion Solutions of Delaware provides patient referral and biologic infusion order forms to help referring providers coordinate treatment.

Where are Infusion Solutions of Delaware’s locations?

Infusion Solutions of Delaware currently has three locations:

Dover: 1100 Forrest Avenue
Milford: 1003 Mattlind Way
Newark: 537 Stanton Christiana Road

How do I get started?

If your physician has prescribed TEPEZZA, LUMVOA, or another specialty infusion medication, talk with your healthcare provider about sending a referral to Infusion Solutions of Delaware.

You can also contact the team directly to learn more about the referral, insurance, authorization, and scheduling process.

Specialty Infusion Care Across Delaware

Thyroid Eye Disease treatment can be a journey. Your infusion experience shouldn’t add unnecessary stress to it.

At Infusion Solutions of Delaware, our goal is to provide high-quality outpatient infusion therapy in a convenient, accessible setting.

With locations in Dover, Milford, and Newark, support for Medicare and many major insurance plans, and assistance coordinating referrals, insurance requirements, and prior authorizations, our team is here to help make the process easier.

If you’ve been prescribed TEPEZZA®, LUMVOA™, or another specialty infusion therapy, talk with your healthcare provider and contact Infusion Solutions of Delaware to get started.

Infusion Solutions of Delaware
Dover | Milford | Newark

302-674-4627

Visit Infusion Solutions of Delaware